EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma

Keval Yerigeri, Manjistha Sengupta, Jingli Zhang, Jeevan Puthiamadathil, Raffit Hassan

Clinical Lung Cancer · 2026-06 · 27 (5) · 77-86.e1

DOI: 10.1016/j.cllc.2026.04.005 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Lung Cancer, 2026-06. Verfasst von Keval Yerigeri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine-Pediatrics, Case Western Reserve University, The MetroHealth System, Cleveland, OH. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Inflammation, Mesothelioma, Peritoneal Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Center for Cancer Research, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorInflammationMesotheliomaPeritoneal NeoplasmsPleural NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedC-Reactive ProteinCA-125 AntigenFibrinogenGPI-Linked ProteinsMesothelinMesothelioma, MalignantNeutrophilsPrognosisSurvival Rate

Stichwörter der Autor:innen

C-reactive proteinCA125Megakaryocyte potentiating factorMesothelinPlatelet counts

Substanzen

Biomarkers, TumorC-Reactive ProteinCA-125 AntigenFibrinogenGPI-Linked ProteinsMesothelin

Autor:innen und Institutionen

  • Department of Internal Medicine-Pediatrics, Case Western Reserve University, The MetroHealth System, Cleveland, OH.
  • Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD.
  • Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Electronic address: Jeevan.Puthiamadathil@fda.hhs.gov.
  • Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD. Electronic address: hassanr@mail.nih.gov.

Förderung

  • Intramural NIH HHS
  • Center for Cancer Research
  • U.S. Department of Health and Human Services
  • Colgate-Palmolive
  • National Institutes of Health
  • National Institutes of Health National Cancer Institute
  • Doris Duke Charitable Foundation
  • American Association for Dental, Oral, and Craniofacial Research

Zitieren

APA

Yerigeri, K., Sengupta, M., Zhang, J., Puthiamadathil, J., & Hassan, R. (2026). Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. Clinical Lung Cancer, 27(5), 77-86.e1. https://doi.org/10.1016/j.cllc.2026.04.005

Vancouver

Yerigeri K, Sengupta M, Zhang J, Puthiamadathil J, Hassan R. Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. Clinical Lung Cancer. 2026;27(5):77-86.e1. doi:10.1016/j.cllc.2026.04.005

BibTeX
@article{Yerigeri2026,
  author = {Yerigeri, Keval and Sengupta, Manjistha and Zhang, Jingli and Puthiamadathil, Jeevan and Hassan, Raffit},
  title = {Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma},
  journal = {Clinical Lung Cancer},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {77--86.e1},
  doi = {10.1016/j.cllc.2026.04.005}
}
Kostenlos starten →